FDA Watch: Labcorp Gets Companion Diagnostic Approval for Advanced Melanoma Test
Company also announces distribution of newly approved Alzheimer’s assay
Company also announces distribution of newly approved Alzheimer’s assay
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The agency has approved fewer than 10 tests in the past three years, but a new pipeline of AI-powered products is expected to emerge soon
Laboratory diagnostics manufacturers receive regulatory scrutiny for issues including marketing, quality, and unapproved changes to tests
Regulatory expert Julie Ballard shares her first thoughts on the final rule for lab-developed tests and immediate steps for labs
Prenosis claims its test can detect the presence of the often deadly condition within 24 hours of a hospitalization
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
Whether the MiniDraw™ device dredges up memories of Theranos’ failed tech remains to be seen.
First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.